NGT: Next-Generation Technologies for Next-Generation Cancer Models

Next-Generation Technologies (NGT) Program supports the development of technology tools that will facilitate and/or accelerate research using advanced human-derived next-generation cancer models such as organoids, conditionally reprogrammed cells, and others. The tools will focus on utilizing next-generation cancer models from the Human Cancer Models Initiative.

Banner for Next-Generation Technologies for Next-Generation Cancer Models

News & Publications

View In the News Page
previousnext
OCG Programs' Resources
June 04, 2021

Poster Presentation at Virtual AACR Annual Meeting 2021

Office of Cancer Genomics presented a poster titled " NCI Office of Cancer Genomics: Multidisciplinary Genomic Research Initiatives Drive Discovery Towards the Clinic" at the virtual American Association for Cancer Research (AACR) annual meeting from April 10-15.

See the poster...

Banner for Next-Generation Technologies Program
February, 2021

Next-Generation Technologies for Next-Generation Cancer Models

The Next-generation Technologies for Next-generation Cancer Models Program (NGT; RFA-CA-19-055) supports the development of technologies and tools that will facilitate...

Julyann Pérez-Mayoral, Ph.D.
August, 2020

Contributing to Precision Oncology by Expanding Basic Research Capacities Using Next-generation Cancer Models

As a basic cancer researcher, I am interested in ways to expand the capacities of researchers to explore new pathways and treatment options that can lead to acceleration of personalized treatments at the bedside. During my last year of postdoctoral training, I realized I wanted to transition to...

OCG Resources word art
December, 2019

OCG-supported Initiatives Provide Valuable Resources to Advance and Accelerate Precision Oncology

Cancer is a global disease that calls for scientists and clinicians from around the world to join forces to advance their collective efforts. Advances in genomic studies such as high-throughput sequencing has made it possible to characterize genomes from many cancer types and learn about the...

Headshot of Dr. Lauren Hurd
August, 2019

Leveraging a Genomics Background to Facilitate Molecular Characterization of HCMI Models

My name is Lauren Hurd and I am a Scientific Program Manager for the Human Cancer Models Initiative (HCMI) within the Office of Cancer Genomics (OCG). National Cancer Institute (NCI), together with other consortium members, co-...

O
O
O
O
O
Last updated: June 03, 2021

Content on this page maintained by the Office of Cancer Genomics